Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

Roche

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.

Roche

UICC launches global ATOM Coalition to increase access to essential cancer medicines

UICC launches global ATOM Coalition to increase access to essential cancer medicines Teresa Graham, head of global product strategy, Roche Pharma, said: “Improving global access to quality cancer care is a core commitment at Roche.

Roche collaborates with Global Fund to strengthen critical diagnostics infrastructure

Roche collaborates with Global Fund to strengthen critical diagnostics infrastructure A new collaboration has been announced between Roche and The Global Fund (The Global Fund) to Fight AIDS, Tuberculosis (TB) and Malaria. ... He added: “We are pleased to partner with Roche in expanding access to diagnostics tools for HIV and TB.

Roche reinforces commitment to the World Federation of Hemophilia Humanitarian Aid Program

Roche reinforces commitment to the World Federation of Hemophilia Humanitarian Aid Program Roche has extended its commitment to the World Federation of Hemophilia (WFH) Humanitarian Aid Program until the end of 2028. ... Bill Anderson, CEO Roche Pharmaceuticals, commented: “Our renewed commitment will allow us to continue to help people with

Roche’s Evrysdi improves survival rates for infants with SMA

Roche’s Evrysdi improves survival rates for infants with SMA Roche has released three-year data from its FIREFISH study, including one-year data from the open label extension. ... Without treatment, they would typically not survive beyond two years of age,” said Levi Garraway, chief medical officer and head of

Roche shares new positive Ocrevus data for MS patients

Roche shares new positive Ocrevus data for MS patients Roche has shared new Ocrevus (ocrelizumab) data that demonstrates its benefit on disease progression and cognitive outcomes in primary progressive multiple sclerosis (PPMS) and secondary progressive MS (SPMS).

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....